Home Cart Sign in  
Chemical Structure| 76-90-4 Chemical Structure| 76-90-4

Structure of Mepenzolate bromide
CAS No.: 76-90-4

Chemical Structure| 76-90-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mepenzolate bromide mAchR antagonist, working as a post-ganglionic parasympathetic inhibitor to decrease gastric acid and pepsin secretion and suppresse spontaneous contractions of the colon.

Synonyms: Mepenzolate (bromide); NSC 4358; mepenzolic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mepenzolate bromide

CAS No. :76-90-4
Formula : C21H26BrNO3
M.W : 420.34
SMILES Code : C[N+]1(C)CC(OC(C(C2=CC=CC=C2)(O)C3=CC=CC=C3)=O)CCC1.[Br-]
Synonyms :
Mepenzolate (bromide); NSC 4358; mepenzolic acid
MDL No. :MFCD00079450

Safety of Mepenzolate bromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO-K1 cells 10^-11 to 10^-6 M 2 hours To determine the binding affinity of compounds to hM3R and hM2R, results showed that MP-AD had the highest affinity for hM3R. Front Pharmacol. 2018 Apr 10;9:344

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Elastase-induced pulmonary emphysema model Intratracheal, oral, intravenous, intrarectal 38-940 µg/kg Once daily for 12 days Evaluate the efficacy and side effects of different administration routes of mepenzolate in treating COPD. Results showed that intratracheal administration effectively suppressed elastase-induced pulmonary damage and bronchodilation at lower doses with fewer side effects. Sci Rep. 2014 Mar 28;4:4510
Rats Iodoacetamide-induced colitis model Intraperitoneal injection 5 mg/kg/day Once daily for 2 weeks Mepenzolate bromide, as a GPR109A receptor blocker, abolished the protective effects of niacin on body weight, colon wet weight, and colonic levels of MPO and VEGF. Sci Rep. 2017 Aug 2;7(1):7139
Db/db mice Type 2 diabetic animal model Topical administration 600 μg/kg 3 consecutive days Mepenzolate bromide significantly promoted diabetic wound healing by inhibiting inflammatory responses and reducing oxidative stress. Am J Transl Res. 2016 Jun 15;8(6):2738-47

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.90mL

2.38mL

1.19mL

23.79mL

4.76mL

2.38mL

References

 

Historical Records

Categories